DRS176735_1.png

Madopar 250 Tablet

Therapeutic Class: NEURO CNS
Manufacturer:
Get Quote

Madopar 250 Tablet is a combination of two medicines: Levodopa and Benserazide which treats Parkinsonism. Levodopa is a dopamine precursor which gets converted to dopamine, a chemical messenger that controls movement in the brain. Benserazide is a peripheral decarboxylase inhibitor which prevents breakdown of levodopa allowing it to enter the brain and increase dopamine levels. (N. Chimanlal Enterprises – Exporter of ABBOTT Branded & Generic Products Mumbai INDIA)

Salt Composition: Levodopa (200mg) + Benserazide (50mg)
Strength: Levodopa (200mg) + Benserazide (50mg)
Pack Size: strip of 10 tablets
Uses: Parkinson's disease
Table Header
Salt Composition
Levodopa (200mg) + Benserazide (50mg)
Strength
Levodopa (200mg) + Benserazide (50mg)
Pack Size
strip of 10 tablets
Uses
Parkinson’s disease
DISCLAIMER
Niche Formulations (www.nicheformulations.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India. Product is supplied for Tenders/ Emergency imports/ Un ? licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Product names, logos, brands and other trademarks featured or referred to are the property of their respective Trademark Holders. The information provided here is for Informational purposes only.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories

Select at least 2 products
to compare